Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML

Author(s):

Jessica M. Salmon, Izabela Todorovski, Kym L. Stanley, Claudia Bruedigam, Conor J. Kearney, Luciano G. Martelotto, Fernando Rossello, Timothy Semple, Gisela Mir Arnau, Magnus Zethoven, Michael Bots, Stefan Bjelosevic, Leonie A. Cluse, Peter J. Fraser, Veronique Litalien, Eva Vidacs, Kate McArthur, Antony Y. Matthews, Elise Gressier, Nicole A. De Weerd, Jens Lichte, Madison J. Kelly, Simon J. Hogg, Paul J. Hertzog, Lev M. Kats, Stephin J. Vervoort, Daniel D. De Carvalho, Stefanie Scheu, Sammy Bedoui, Benjamin T. Kile, Steven W. Lane, Andrew C. Perkins, Andrew H. Wei, Pilar M. Dominguez, Ricky W. Johnstone

Details:

Cancer Discovery, Volume 12, Issue 6, 2022-06-01

Article Link: Click here

Affiliations:

• University of Melbourne
• The University of Queensland
• Monash University
• Universiteit van Amsterdam
• University of Toronto Faculty of Medicine
• Heinrich-Heine-Universität Düsseldorf
• Princess Margaret Cancer Centre
• Peter Maccallum Cancer Centre
• QIMR Berghofer Medical Research Institute
• Faculty of Health and Medical Sciences
• Hudson Institute of Medical Research
• Department of Microbiology & Immunology
• Department of Clinical Pathology